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Associations of Rheumatoid Arthritis and Depressive
Symptoms Over Time: Are There Differences
by Education, Race/Ethnicity, and Gender?
Julia McQuillan,1 Jennifer A. Andersen,2

Terceira A. Berdahl,3 and Jeff Willett4

Objective. To examine associations between changes in rheumatoid arthritis (RA) symptoms and depressive
symptoms adjusted for other time-varying characteristics, and to test if these associations differed by education,
race/ethnicity, or gender.
Methods. Data from the 1988–1998 US National Rheumatoid Arthritis Study were analyzed (n = 854). Time-varying
covariates included year of the study, pain, functional ability, household work disability, parental status, marital status,
employment status, and social support. The time-invariant covariates included years since diagnosis, education, race/
ethnicity, and gender. Multivariate multilevel-model analyses were used to estimate associations within people over time.
Results. Patients with RA experience considerable change in depressive symptoms, pain, functional disability, and
household work disability over the study period. Depressive symptoms were driven more by differences between people compared to changes within people over time. Findings show that patients experienced increases in depressive
symptoms over the study period. The rate of change in depressive symptoms did not differ by education, race/ethnicity, or gender. Times of worse pain, functional disability, and household disability were associated with worse depressive symptoms. The association of functional disability and depressive symptoms was stronger for men than women.
Conclusion. Increases in pain and disability were associated with worse depressive symptoms, adjusted for covariates. It is important to monitor and treat both mental and physical health symptoms. Future research efforts should
focus on collecting data reﬂecting the educational, gender, and racial/ethnic diversity of individuals with RA.
INTRODUCTION
Rheumatoid arthritis (RA) is a chronic autoimmune disease
affecting 54.4 million individuals in the US (~1% of the population)
(1,2). RA is more prevalent among women than men and is a leading cause of work-related disability in the US (1). Since the late
1990s, advances in drug therapies have contributed to improved
outcomes for patients with RA; however, some still have considerable physical and mental health effects from RA (3,4). Depression is
more common among individuals with RA than in the general population, and although numerous studies document the physiology
of RA, fewer focus on the dynamic associations of biological, psychological, and social dimensions of RA in a single study (2,4–6).
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Research on RA suggests that social roles and conditions,
not just biological changes in the body (7), matter for good health.
In addition to higher pain, fatigue, and disability, depressive symptoms may also be higher among individuals with RA compared to
those without RA (8). There is considerable variation in the extent
of depressive symptoms among patients with RA (6), and
increases in symptom severity (e.g., pain, disability), a greater
number of difﬁcult life experiences (e.g., job loss, relationships
ending), and fewer social resources (e.g., less social support) are
all associated with higher depressive symptoms (3). Belonging to
a socially disadvantaged group (e.g., women, people of color,
people with lower education) is also associated with higher
depressive symptoms in the general population (9).
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SIGNIFICANCE & INNOVATIONS
• Changes in pain, functional disability, and household work disability were associated with changes
in depressive symptoms for individuals with rheumatoid arthritis.
• Changes in marital status and employment were
associated with changes in depressive symptoms
over time.
• The association between pain and depressive
symptoms was stronger for women compared to
men; the association between functional disability
and depressive symptoms was stronger for men
compared to women.
• Education modiﬁes the association of social support
and depressive symptoms; the association was
stronger for individuals with lower education.
• Patients varied in how much pain, functional disability, household work disability, and social circumstances mattered for depressive symptoms.

Individuals with more coping resources (e.g., higher education and/or more social support) are less vulnerable to psychological distress when they experience stressors such as pain or
disability (10,11). Historic and contemporary racism also
increases stressors and reduces coping resources for people of
color compared to people who are White (12,13). Social expectations based on gender, for example, about employment or household duties, can shape the meaning of symptoms beyond the
physical experience (14). Alternatively, physiological stress processes (e.g., HPA axis) involved with RA and depression could
be direct and not modiﬁed by social determinants such as education, race/ethnicity, or gender (15,16).
Although often assumed, it is necessary to examine if the
association of greater RA symptoms with higher depressive
symptoms occurs within people over time, and if social statuses
(e.g., gender) modify the association (17–19). The current study
is guided by the social determinants of health (20), biopsychosocial model of health (21), and health disparities (14,22,23) frameworks and answers the following questions: 1) Are within-person
changes in RA illness (i.e., changes in pain, functional impairment,
and household work disability) associated with changes in
depressive symptoms (focal associations)? 2) Do the focal associations persist after controlling for changes in demands and
resources (e.g., marital status, parenthood status, employment
status, and social support)? 3) Do between-person indicators of
social status/social inequality (i.e., education level, race/ethnicity,
or gender) modify the within-person focal associations?

PATIENTS AND METHODS
Respondents (patients). The data for this study come
from the National Rheumatoid Arthritis Study (NRAS), a prospective

panel, which completed its tenth and ﬁnal year in 1997–98. This
unique panel of 988 patients with RA were recruited from a national,
random sample of board-certiﬁed rheumatologists (24). On average, respondents had depressive symptom scores (mean ± SD
11.57 ± 10.52) below the cutoff level of 16, the threshold indicating
a high likelihood of meeting diagnostic criteria for depression
(25–27). In addition, the study respondents were mostly middleaged (mean ± SD 58 ± 9.7 years), married (68%), out of the labor
force (65%), and women (83%), similar to the 3:1 prevalence of
RA among middle-aged women compared to men and the relatively low employment rate found in similar samples of RA patients
(28) (Table 1). Over the 10 years of the study, 46% of people
remained in the sample for all waves of data collection. A prior
analysis of the NRAS found that those in the ﬁnal wave were more
educated, more likely to be women, had higher levels of social support, had fewer joint groups with ﬂares, and were more likely to be
employed compared to the initial sample (24). The analytic sample
includes 8 of the 10 waves (excluding the ﬁrst and fourth waves
because they did not include the variables of interest) and data from
the 854 respondents who had at least 2 waves of complete data.
Concepts and measures. Depressive symptoms, the
dependent variable, was assessed by the 20-item Center for
Epidemiologic Studies Depression Scale (CES-D) depression
scale in each year of the study. The CES-D contains 20 items
measuring depressed mood, guilt, helplessness, slowness of
psychomotor tasks, loss of appetite, and sleep disturbance
(25–26,29). The CES-D scale is reliable (α = 0.85) in population
studies (28). The CES-D is also reliable in a sample of patients
with RA (30), and a score of ≥16 indicates a high likelihood of
meeting diagnostic criteria for depression (25,26).
Pain was assessed each year by the question, “How
much arthritis pain have you felt (past week)?” Scores range
from 0–100 (0 = no pain). Asking about pain in this manner is
reliable, valid, and sensitive to disease symptoms in various
settings (27).
Functional disability was assessed each year with the
Stanford Health Assessment Questionnaire (HAQ) (31), shortened
to reduce the burden of a long questionnaire and to avoid issues
of correlation with other dimensions of disability (32). The shortened HAQ is not directly comparable to the original; however, it
is a measure of arthritis-associated disability (33). The HAQ score
is the average of answers to a standard series of questions about
the ability to do speciﬁc tasks, such as open car doors, take a
bath, and lift a 5-pound bag of sugar. Items were measured on a
scale from 0 (with no difﬁculty) to 3 (unable to do). Cronbach’s α
across all waves of data ranged from 0.91 to 0.94 (34).
Household work disability was assessed each year by the
question, “Thinking about how arthritis affects your ability to do
your household responsibilities, would you say that you are doing
more (=1), the same (=2), same but with difﬁculty (=3), or that you
have cut down (=4)?” This measure is designed to capture the
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Table 1. Descriptive statistics for all study variables*
Within-person time-varying variables
Outcome, mean ± SD
Depressive symptoms (CES-D)
RA symptoms, mean ± SD
Pain (0 = no pain to 100 = extreme pain)
Functional inability (HAQ) (3 = unable to do)
Household work disability (4 = cut down)
Demands and resources
Parent of children age <16 years (= 1; not parent = 0)
Married (= 1; not married = 0)
Employed (= 1; not employed = 0)
Social support (4 = high support), mean ± SD
Between-person variables
Social location
Education, years, mean ± SD
Race/ethnicity (POC = 1; White = 0)
Sex (men = 1, women = 0)
Indicators of time, mean ± SD
Length of time with RA, years
Survey wave (7 = 10th survey)

Value

Range

11.57 ± 10.52

0–57

46.45 ± 29.66
0.74 ± 0.56
2.72 ± 0.89

0–100
0–3
1–4

0.22
0.70
0.41
3.16 ± 0.55

0–1
0–1
0–1
1–4

12.84 ± 2.41
0.11
0.22

3–10
0–1
0–1

10.16 ± 8.58
4.01 ± 2.27

0–43
0–7

* Values are the proportion unless indicated otherwise. Source is the National Rheumatoid Arthritis study (person-years: n = 4,798; participants: n = 854). For variables that change wave to wave,
the grand mean across all persons and all waves is provided; for variables that do not change by
wave, the values come from the ﬁrst wave. CES-D = Center for Epidemiologic Studies Depression
Scale; HAQ = Health Assessment Questionnaire; POC = person of color; RA = rheumatoid arthritis.

unpaid work that women are more likely to be accountable
for (17).
Social roles and social support were measured each year by
social role indicator variables for being a parent of a child
≤16 years (=1 versus not a parent), being married (=1 versus not
married = 0), or being employed (=1 versus not employed). Social
support was measured each year using a subset of items from the
Berkman Social Network Inventory (18). The social support scale
is an average of the items assessing social support (e.g., “The
important people in my life accept me as I am,” “There is someone who will give me a hug when I need comforting,” and “There
is someone whose advice I really trust”). Cronbach’s α across all
waves of data for the social support scale ranged from 0.84
to 0.87.
Education, race/ethnicity, and gender were measured in the
ﬁrst year of the survey. Education is reported in categories
(e.g., less than a high school degree, high school degree or
some college, college degree or more) in the descriptive statistics and in the number of years of education completed in the
multivariate analyses. Racial/ethnic status was reported by the
participant. A small portion of the sample selected a category
that indicated a status as a person of color (12.5%). Most were
Black (6%), followed by 3% Hispanic, 2.5% Asian, and 1%
“other racial/ethnic group.” To indicate vulnerability to consequences from racial inequity and to accommodate the small
number of people in each group, we compare people of color
(=1) with people who said they were White (=0). To measure
gender, we used an indicator variable for the sex category (men
[=1] compared to women [=0]).

Measures of time. We also controlled for the length of time
living with RA in the ﬁrst year of the study (a person-level characteristic measured in years) and study year (a within-person
level measure of time) that ranges from 0 (second year of data
collection) to 7 (tenth and ﬁnal).
Statistical approach/analysis. Repeated annual
surveys created up to 8 observations for each participant for
each time-varying variable (within-person). To appropriately
model the observations nested within persons and to handle
missing observations, we use multilevel models (MLMs) (19).
MLMs estimate variance within and between persons even
when there are varying amounts of missing observations
(e.g., if a person skips a year). Including variables in the analyses
as deviation scores (person-centered) around each person’s
own mean aids in meaningful interpretation (i.e., “0” represents
each person’s own mean) (35). The deviation scores index the
year-to-year within-person change relative to each person’s
average level for each time-varying variable. At the betweenperson level, the scores are deviations from the overall sample
average to indicate higher or lower scores relative to others in
the sample (grand mean centered). The term “change” indicates
the within-person deviation scores, and “difference” indicates
the between-person level comparisons.
The descriptive statistics were estimated using SPSS,
version 23, and the multivariate longitudinal regression models
were estimated using HLM, version 8 (Scientiﬁc Software International). Summary statistics and ranges for the variables are in
Table 1, and summary statistics are in Table 2 by education,

12.45 ± 9.06
48.26 ± 22.79
0.76 ± 0.51
2.79 ± 0.60
0.29
0.73
0.48
3.15 ± 0.49
12.63 ± 0.94
0.19
0.09
9.96 ± 8.51

16.98 ± 10.57

55.5 ± 24.99
0.95 ± 0.58

2.91 ± 0.57

0.17

0.67
0.23
3.00 ± 0.54

9.14 ± 1.87

0.31
0.21

10.45 ± 8.59

HS/some college
(n = 563)

10.48 ± 8.83

0.27
0.10

16.47 ± 0.52

0.70
0.66
3.14 ± .048

0.031

2.63 ± 0.54

38.72 ± 21.98
0.58 ± 0.55

8.73 ± 9.70

BA+
(n = 165)

0.774

0.004
0.001

0

0.425
0.000
0.004

0.012

<0.001

<0.001
<0.001

<0.001

P

10.29 ± 8.78

0.23
–

12.93 ± 2.33

0.72
0.48
3.15 ± 0.49

0.26

2.77 ± 0.59

46.74 ± 23.39
0.74 ± 0.53

12.19 ± 9.41

White
(n = 746)

8.89 ± 6.67

0.19
–

12.08 ± 2.93

0.64
0.44
2.98 ± 0.53

0.38

2.84 ± 0.60

53.88 ± 23.49
0.89 ± 0.63

14.35 ± 10.41

POC
(n = 96)

Race/ethnicity

0.040

0.359
–

0.011

0.134
0.492
0.004

0.026

0.332

0.007
0.051

0.081

P

10.13 ± 8.45

–
0.12

–
0.09
10.15 ± 9.00

12.86 ± 2.34

0.67
0.44
3.14 ± 0.50

0.27

2.79 ± 0.57

48.52 ± 23.13
0.81 ± 0.54

13.00 ± 9.59

Women
(n = 666)

12.75 ± 2.68

0.85
0.60
3.10 ± 0.50

0.27

2.73 ± 0.65

44.16 ± 24.49
0.57 ± 0.50

10.47 ± 9.12

Men
(n = 194)

Gender
P

0.916

–
0.358

0.676

<0.001
<0.001
0.353

0.911

0.204

0.026
0.000

0.001

* Values are the proportion unless indicated otherwise. Source is the National Rheumatoid Arthritis study (person-years: n = 4,798; participants: n = 854). Independent samples t-test for
sex and race; analysis of variance test for education level. BA = Bachelor’s degree; CES-D = Center for Epidemiologic Studies Depression Scale; HS = high school; POC = person of color;
RA = rheumatoid arthritis.

Depressive symptoms
(CES-D), mean ± SD
Pain, mean ± SD
Functional disability,
mean ± SD
Household work
disability, mean ± SD
Parent of children age
<16 years
Married
Employed
Social support,
mean ± SD
Education, mean ± SD
years
Men
Minority race/ethnicity
(POC)
Length of time with RA,
mean ± SD years

<HS
(n = 132)

Education

Table 2. Descriptive statistics for study variables (aggregated across study waves to the person level)*
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Table 3. Multilevel model of changes in depressive symptoms by changes in rheumatoid arthritis symptoms, social roles, social support, and the
modifying effects of social inequality indicators*
Model 1
Intercepts (mean CES-D score), π0
Intercept for intercept, β00
Years since diagnosis, β01
Education, years, β02
POC (ref. White), β03
Men (ref. women), β04
Pain, β05
Functional disability, β06
Household work disability, β07
Social support, β08
Slope for “Study year,” π1
Intercept for “Study year,” β10
Years since diagnosis, β11
Education, years, β12
POC (ref. White), β13
Men (ref. women), β14
Slope for “Pain,” π2
Intercept for “pain,” β20
Years since diagnosis, β21
Education, years, β22
POC (ref. White), β23
Men (ref. women), β24
Slope for “Functional disability,” π3
Intercept for “Functional disability,” β30
Years since diagnosis, β31
Education, years, β32
POC (ref. White), β33
Men (vs. women), β34
Slope for “Household work disability,” π4
Intercept for “Household work disability,” β40
Years since diagnosis, β41
Education, years, β42
POC (ref. White), β43
Men (ref. women), β44
Slope for “Parent,” π5
Intercept for “Has a child,” β50
Years since diagnosis, β51
Education, years, β52
POC (ref. White), β53
Men (ref. women), β54
Slope for “Married,” π6
Intercept for “Married,” β60
Years since diagnosis, β62
Education, years, β63
POC (ref. White), β63
Men (ref. women), β64
Slope for “Employed,” π7
Intercept for “Employed,” β70
Years since diagnosis, β71
Education, years, β72
POC (ref. White), β73
Men (ref. women), β74
Slope for “Social support,” π8
Intercept for “Social support,” β80
Years since diagnosis, β81
Education, years, β82
POC (ref. White), β83
Men (ref. women), β84

Model 2

Model 3

Coeff.

SE

P

Coeff.

SE

P

Coeff.

SE

P

10.19
–0.06
–
–
–
–
–
–
–

0.31
0.03
–
–
–
–
–
–
–

<0.001
0.082
–
–
–
–
–
–
–

11.62
–0.02
–
–
–
–
–
–
–

0.43
0.05
–
–
–
–
–
–
–

<0.001
0.65
–
–
–
–
–
–
–

12.25
–0.02
–0.39
–0.48
–2.38
0.04
–0.32
0.90
–1.13

0.48
0.05
0.19
1.46
1.02
0.01
0.77
0.45
0.55

<0.001
0.789
0.037
0.767
0.019
0.001
0.783
0.044
0.053

0.36
0.00
–
–
–

0.05
0.01
–
–
–

<0.001
0.908
–
–
–

0.29
0
–
–
–

0.05
0.01
–
–
–

<0.001
0.626
–
–
–

0.25
0.00
0.00
–0.02
0.03

0.06
0.01
0.02
0.17
0.10

<0.001
0.642
0.863
0.930
0.782

0.04
0.00
–
–
–

0.01
0.00
–
–
–

<0.001
0.476
–
–
–

0.04
0.00
–
–
–

0.01
0
–
–
–

<0.001
0.478
–
–
–

0.04
0
0
–0.01
–0.04

0.01
0
0
0.02
0.01

<0.001
0.479
0.479
0.404
<0.001

6.58
–0.02
–
–
–

0.38
0.04
–
–
–

<0.001
0.556
–
–
–

5.70
–0.01
–
–
–

0.38
0.04
–
–
–

<0.001
0.843
–
–
–

4.45
0
–0.09
0.50
2.68

0.52
0.04
0.16
1.08
0.86

<0.001
0.882
0.596
0.769
0.001

0.65
–0.03
–
–
–

0.14
0.01
–
–
–

<0.001
0.051
–
–
–

0.94
–0.02
–
–
–

0.13
0.01
–
–
–

<0.001
0.189
–
–
–

1.03
–0.02
0.03
–0.87
–0.21

0.16
0.01
0.06
0.45
0.30

<0.001
0.166
0.630
0.070
0.393

–
–
–
–
–

–
–
–
–
–

–
–
–
–
–

0.13
0.01
–
–
–

0.28
0.03
–
–
–

0.280
0.032
–
–
–

–0.10
0.01
0.07
1.25
0.47

0.33
0.03
0.13
0.78
0.72

0.986
0.799
0.590
0.134
0.651

–
–
–
–
–

–
–
–
–
–

–
–
–
–
–

–1.25
–0.03
–
–
–

0.40
0.05
–
–
–

0.002
0.590
–
–
–

–1.31
–0.04
–0.04
–0.34
1.77

0.45
0.05
0.17
1.13
0.93

0.003
0.331
0.860
0.656
0.039

–
–
–
–
–

–
–
–
–
–

–
–
–
–
–

–0.98
–0.02
–
–
–

0.30
0.04
–
–
–

0.001
0.694
–
–
–

–0.48
–0.02
–0.06
–0.29
–0.28

0.37
0.04
0.13
0.95
0.66

0.249
0.529
0.600
0.784
0.694

–
–
–
–
–

–
–
–
–
–

–
–
–
–
–

–4.07
0.01
–
–
–

0.29
0.03
–
–
–

<0.001
0.797
–
–
–

–3.61
0
0.32
0.12
0.26

0.43
0.03
0.13
0.91
0.63

<0.001
0.912
0.021
0.861
0.651

* Source is the National Rheumatoid Arthritis Study; waves 2, 3, 5–10 analyses with HLM, version 8 (Scientiﬁc Software International). Personyears: n = 4,798; participants: n = 854. Within-person continuous variables are deviations from each person’s own mean (person-mean
centered). Between-person continuous variables are deviations from the overall sample mean (grand mean centered). CES-D = Center for
Epidemiologic Studies Depression Scale; coeff. = coefﬁcient; POC = person of color; ref. = reference.
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race/ethnicity, and gender. Tests of the signiﬁcance of the differences between groups used chi-square, t-tests, and analyses of
variance, as appropriate, based on the level of measurement.
Table 3 reports the results of the multilevel models. The unstandardized maximum likelihood coefﬁcients (β coefﬁcients) provide
the effect size estimations of magnitude and direction of changes
in the dependent variable associated with the within-person
changes in the independent variables. Only the slopes with significant variance components were allowed to vary randomly
(unique to each person). Exploration of the normality assumption
indicates scores <1 for kurtosis and skew for all variables, well
within the cutoff points for problematic nonnormality allowing for
the use of parametric tests (30). A baseline model (no predictors)
indicated that 35% of the variance in depressive symptoms was
within persons and 65% was between persons. Preliminary models with each covariate as an outcome and study year as the predictor revealed signiﬁcant change over time for all variables
(P < 0.05 for the “study year” indicator).

RESULTS
Depressive symptoms, pain, functional disability, and household work disability differed by level of education; further, pain differed by race/ethnicity, and depressive symptoms, pain, and
functional disability differed by gender (Table 2). These bivariate
differences indicate likely health disparities among patients with
RA. Consistent with prior research, between-person comparisons indicate that depressive symptoms were highest among
those with lower education and among women (Table 2). The
higher depressive symptoms among people of color compared
to people who were White did not reach the conventional level of
statistical signiﬁcance (0.081 > 0.050). Reported levels of pain,
functional disability, and household work disability were higher
for those with lower education, people of color, and women. People of color had higher pain than people who were White. Women
had higher pain and worse functional disability than men, but,
contrary to expectation, women did not have higher household
work disability than men. Social support was lowest among those
with lower education and was lower among people of color but
did not differ by gender (Table 2).
The ﬁrst multilevel model showed that each year in the study
was associated with increased depressive symptoms (β = 0.36,
P = <0.001) or about one-third of a symptom (0.03% of an SD
[= 0.36/10.52]) (Table 3, model 1). Adjusted for the time trend,
changes in pain (β = 0.04, P < 0.001), functional disability (β = 6.58,
P < 0.001), and household work disability (β = 0.65, P < 0.001) were
associated with within-person increases in depressive symptoms.
With the addition of parenthood status, marital status,
employment status, and social support as controls (Table 3,
model 2), the associations of pain, functional disability, and
household work disability with depressive symptoms persisted.
Changes in parenthood status were not associated with changes
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in depressive symptoms. People who were married (β = –1.25,
P = 0.002), employed (β = –0.98, P = 0.001), and reported higher
social support (β = –4.07, P < 0.001) had fewer depressive symptoms compared to those who were unmarried, unemployed, or
had lower social support.
In the full model (Table 3, model 3), there was still a
negative association of education with depressive symptom
scores (β = –0.39, P = 0.037), and men (β = –2.38, P = 0.019)
had lower depressive symptoms than women. The aggregate
scores for pain (β = 0.04, P < 0.001) and the effect of household
work disability (β = 0.90, P < 0.001) had negative associations
with depressive symptoms.
When adjusted for education, race/ethnicity, gender, and
aggregate symptom measures in Table 3 (model 3), only the
change in employment status was no longer associated with
depressive symptoms. Depressive symptoms increased over time
(study year β = 0.25, P < 0.001) and with increased levels of pain
(β = 0.04, P < 0.001), functional disability (β = 4.45, P < 0.001),
and household work disability (β = 1.03, P < 0.001). If patients
were married (β = –1.31, P = 0.003), they had lower depressive
symptoms than if they were not, and, as expected, increases in
social support were associated with lower depressive symptom
scores (i.e., negative association) (β = –3.61, P < 0.001).
Gender modiﬁed the within-person associations of pain,
functional disability, and marital status with depressive symptoms
(Table 3, model 3). On average, results indicate that the association between pain and depressive symptoms was weaker for
men than for women (the main effect for pain was β = 0.04
(P < 0.001), and the coefﬁcient for men was negative (β = –0.04,
P < 0.001). In the ﬁnal model, the coefﬁcient for marital status indicated fewer depressive symptoms if women were married compared to if they were not (β = –1.31, P = 0.003). The cross-level
interaction of gender by marital status was positive and stronger
for men (β = 1.77, P = 0.039), indicating that the association was
weaker and positive for men. Men also had a stronger association
of functional disability and depressive symptoms than women (the
main effect for functional disability was β = 4.45 [P < 0.001], and
the coefﬁcient for men was positive and stronger [β = 2.68,
P = 0.001]). Level of education modiﬁed the within-person association of social support and depressive symptoms. Because the
main effect was negative (β = –3.61, P < 0.001) and the interaction coefﬁcient was positive (β = 0.32, P = 0.021), the interaction
indicates a weaker coefﬁcient for social support for each additional year of education.

DISCUSSION
Consistent with prior studies focused on parts of the biopsychosocial model (8), our ﬁndings show that changes in pain,
disability, social roles (marital status and employment), and
social support are associated with changes in depressive symptoms. Within-person changes in pain, functional impairment, and
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household work disability were associated with changes in
depressive symptoms. These associations persisted after controlling for covariates, and there were substantial differences in
depressive symptoms between persons. Gender modiﬁed the
associations of pain, functional disability, and marital status;
education modiﬁed the association of social support with
depressive symptoms.
Our study also provides support for the importance of understanding the connection between pain, functional disability, and
depressive symptoms for individuals with RA (36,37). For those
with RA, changes in symptoms may be a reminder of the incurable nature of RA and a sign that current treatment methods are
not working (36,37), potentially contributing to worsening depressive symptoms. It is possible, however, that the underlying physiology that leads to arthritic inﬂammation also contributes to
depressive symptoms (e.g., HPA axis) (36,38,39). Prior studies
show that the physiological effects of meeting clinical criteria for
depression, anxiety, or both are associated with worse fatigue
trajectories compared to those who did not meet criteria for
depression and/or anxiety (40).
The within-person associations of pain, disability, and
depressive symptoms persisted after controlling for parental status, marital status, employment status, and social support, which
indicates a direct association. Women experience fewer depressive symptoms when they are married, but men do not, suggesting that marriage has different implications for RA and depressive
symptoms for women and men. The association of being
employed with lower depressive symptoms does not persist after
controlling for education, gender, and race/ethnicity (the association exists in model 2 but not model 3 of Table 3). There are several likely ways that social status contributes to depressive
symptoms, including a sense of control (41), ability to maintain
the expectations of core social roles (e.g., spouse/employee)
(42), and the ability to garner coping resources in the face of
stressors (24). The results from this study are consistent with all
of these explanations; however, further research is needed to
explore the complex interactions between employment status,
education, and depressive symptoms for individuals with RA (42).
Surprisingly, the multivariate models exploring race/ethnicity
indicated nonsigniﬁcant coefﬁcients for people of color. Racism
and discrimination have been shown to lead to worse health outcomes for people of color (12); therefore, the expectation would
be for the results to echo previous research ﬁndings among people of color with RA. The SEs for the race/ethnicity coefﬁcients
were large, suggesting that this small subgroup is heterogeneous,
thus making it difﬁcult to detect effects. Rheumatology studies
struggle to include sufﬁcient numbers of people of color in study
samples. In order to make progress in understanding how historical experiences with racism and discrimination impact health outcomes, researchers need to make more concerted efforts to
recruit racial and ethnic minorities into research studies (43). Ideally, future studies will include sufﬁcient cases to analyze health
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disparities among people with RA from an intersectional framework (e.g., using interactions for education by race/ethnicity by
gender) to provide a more comprehensive picture of health
disparities in this population (13).
Our study has several important limitations. The data set
used in the present study was collected during a time when
accommodations for chronic illness in workplaces was less common, high rates of employment for women were new, and insurance was even more closely tied to marriage and employment
(i.e., the 1990s), limiting generalizability to contemporary conditions. There are more effective treatment options for RA now than
in the 1990s (44), which might suggest that fewer people are
vulnerable to depressive symptoms in response to pain, functional disability, and household work disability; however, for those
who still experience more severe RA symptoms, there is likely still
an association with more depressive symptoms. Of course,
improvements in treatment options may be concentrated among
people who are White and/or have better access to medical care,
an issue that also deserves more research (22). Additionally,
because the current study started with patients in rheumatology
practices, there could be important limits to generalizing to those
who are unable to see a specialist (45,46). Some of the ﬁndings
in the current study may be attenuated because those with more
severe RA symptoms or more difﬁcult social circumstances may
also be those least likely to stay in the study (24). Replicating
and expanding the NRAS to include those not in rheumatology
practices who meet criteria for RA, more people of color, and
people in different treatment modalities will be important to check
the robustness of the current ﬁndings.
Even with limitations, the current study highlights the
continuing relevance of social inequality for individuals living with
RA and provides further evidence of the need to understand and
manage differences between patients’ ability to cope with the
stressors associated with RA (47). When rheumatologists ask
patients about mental health issues, individuals with RA are often
willing to discuss them (39). Few physicians have the ability to
reduce the social inequalities that lead to health disparities. Physicians can, however, recognize variations in patient coping
resources and recommend accommodations for employment,
social services, and counseling (39) while keeping the potential
complicating impact of social determinants in mind (39,48,49).
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